Also phill, back in NVAX 3.84 +.42 on this: Rodman & Renshaw, LLC Announces Investment Opinion on Novavax, Inc.
Monday December 5, 10:47 am ET
Rodman & Renshaw, LLC Initiates Coverage of Novavax, Inc. With A Market Outperform Rating
Analyst Sets 12 Month Target Price of $6.00
Consider anything a fish says as borderline entertainment at best, and most likely another lousy stock pick he'll lose his tail on again. circa 2005 source unknown